ORIGINAL RESEARCH
Accepted on 04 Jun 2025
Co-expression of IL-15/IL-15Ra complex enhances NKG2D-CAR T cell-mediated anti-pancreatic cancer immunity by activating the JAK/STAT5 signaling pathway
doi 10.3389/fimmu.2025.1498706
- 141 views
- Frontiers in Oncology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Drug Development for Pancreatic Cancer: Novel Targets, Drug Candidates and Mechanisms
Drug Development for Pancreatic Cancer: Novel Targets, Drug Candidates and Mechanisms
1,138
Total downloads
5,980
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 29 May 2025
Molecular targets and mechanisms of cortex mori for lung cancer treatment: a network pharmacology study, molecular docking and in vitro and in vivo experimental validation
doi 10.3389/fonc.2025.1587856
- 499 views
ORIGINAL RESEARCH
Published on 16 Apr 2025
SUMOylation substrate encoding genes as prognostic biomarkers in pancreatic ductal adenocarcinoma with functional assessment of SAF-B2
doi 10.3389/fphar.2025.1532658
- 784 views
ORIGINAL RESEARCH
Published on 10 Feb 2025
Efficacy of natural killer T and gammadelta T cells in mesothelin-targeted immunotherapy of pancreatic cancer
doi 10.3389/fimmu.2025.1524899
- 2,028 views
Published in
Frontiers in Oncology
Pharmacology of Anti-Cancer Drugs
Participating Journals
Frontiers in Pharmacology
- 4.4 impact factor
- 7.8 citescore